Actinium Pharmaceuticals
ATNM
#10541
Rank
A$44.23 M
Marketcap
A$1.41
Share price
1.00%
Change (1 day)
-48.18%
Change (1 year)

Earnings for Actinium Pharmaceuticals (ATNM)

Earnings in 2026 (TTM): -A$38.13 Million

According to Actinium Pharmaceuticals's latest financial reports the company's current earnings are A$0.09 Million. In 2025 the company made an earning of -A$50.6 Million, an increase over its 2024 earnings that were of -A$58.8 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Actinium Pharmaceuticals from 2007 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$38.13 Million-24.65%
2025 -A$50.6 Million-13.95%
2024 -A$58.8 Million-18.87%
2023 -A$72.47 Million52.24%
2022 -A$47.61 Million36.61%
2021 -A$34.85 Million11.48%
2020 -A$31.26 Million1.46%
2019 -A$30.81 Million-7.37%
2018 -A$33.26 Million-11.46%
2017 -A$37.57 Million10.67%
2016 -A$33.95 Million15.7%
2015 -A$29.34 Million-14.86%
2014 -A$34.46 Million129.19%
2013 -A$15.04 Million-8.55%
2012 -A$16.44 Million
2010 A$0.01 M-152.15%
2009 -A$0.03 Million-39.8%
2008 -A$0.04 Million120.29%
2007 -A$0.02 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Genocea Biosciences
GNCA
-A$51.92 Million 45.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
A$0.26 M-100.75%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.53 B-1,611.42%๐Ÿ‡บ๐Ÿ‡ธ USA